Immunology News and Research

Latest Immunology News and Research

Exploring the possibility of a broadly effective dengue vaccine

Dengue is on the rise, with about 20,000 patients dying each year from this mosquito-borne disease, yet despite ongoing efforts a broadly effective dengue vaccine is not available.

15 May 2019

Low humidity could be flu virus' best friend

Yale researchers have pinpointed a key reason why people are more likely to get sick and even die from flu during winter months: low humidity.

14 May 2019

Probiotic-derived molecule optimizes the immune system to combat viral inflammatory diseases

The existence of certain microorganisms in your gut may bolster the immune system's ability to fend off a herpes viral attack that can cause fatal brain inflammation, reports a new City of Hope-led study.

14 May 2019

New technology to tackle the growing menace of indoor air pollution

Researchers are developing low-cost technologies to tackle indoor air pollution that is a growing menace. A new generation of electrostatic filters can capture even the smallest particles of household pollutants, using a little amount of energy.

11 May 2019

Slow-release HIV vaccine shows promise in preclinical trials

A new slow-release vaccine has been shown to boost the immune system’s response to the HIV virus. The vaccine is given in small doses over a period of days, compared to one large dose.

10 May 2019

‘A Vision for Lupus’ report highlights gaps and inconsistencies in care for lupus patients

To support patients, care givers and healthcare professionals on World Lupus Day, an expert-led report, ‘A Vision for Lupus’, has today been published to help highlight gaps and inconsistencies in care and areas for action to address the gaps that can often exist for patients and their families living with lupus, a chronic, inflammatory, autoimmune disease that affects approximately five million people globally.

10 May 2019

HSS researchers provide better understanding of the cellular mechanisms driving rheumatoid arthritis

Newly identified subsets of cell types present in joint tissue in people with rheumatoid arthritis and how they interact may explain why only some people respond to existing medications, according to two studies by co-senior author Laura Donlin, PhD, Co-Director of the Derfner Foundation Precision Medicine Laboratory at Hospital for Special Surgery and collaborating colleagues.

10 May 2019

UNC and partners receive NIH funding to identify chlamydia vaccine

Chlamydia is the most prevalent bacterial sexually transmitted infection (STI) in the world. There is no vaccine to prevent infection. However, researchers from the University of North Carolina at Chapel Hill, in partnership with colleagues at other sites in the US, Europe and Australia, will receive up to $10.7 million over five years from the National Institutes of Health (NIH) to move closer to identifying a vaccine candidate.

10 May 2019

Experts find previously unknown bacterial strain of the genus Leptospira

Experts from MedUni Vienna/Vienna General Hospital have identified a previously unknown bacterial strain of the genus Leptospira.

8 May 2019

Inhibition of ribosome biogenesis as new treatment strategy for advanced cancers

Nearly ninety per cent of all cancer patient deaths are due to metastasis. A study from Uppsala University shows that a process that allows the cells to metastasize is aided by the synthesis of new ribosomes, the cell components in which proteins are produced.

8 May 2019

Researchers create ‘mini-guts’ to explore how gut epithelium respond to gluten in celiac patients

In pursuit of a novel tool for the research and treatment of celiac disease, scientists at the Mucosal Immunology and Biology Research Center at Massachusetts General Hospital have validated the use of intestinal organoids.

8 May 2019

World Asthma Day: How climate change is increasing cases of asthma

A new report suggests that climate change is increasing and exacerbating cases of asthma, and clinicians need to become more 'knowledgeable' about the link.

7 May 2019

Long-standing immunosuppressive drug reduces Zika birth defects in mice

In experiments with pregnant mice infected with the Zika virus, Johns Hopkins Medicine researchers report they have successfully used a long-standing immunosuppressive drug to diminish the rate of fetal deaths and birth defects in the mice's offspring.

From Johns Hopkins Medicine 7 May 2019

Immunology News and Research

Latest Immunology News and Research

Exploring the possibility of a broadly effective dengue vaccine

Low humidity could be flu virus' best friend

Probiotic-derived molecule optimizes the immune system to combat viral inflammatory diseases

New technology to tackle the growing menace of indoor air pollution

Slow-release HIV vaccine shows promise in preclinical trials

‘A Vision for Lupus’ report highlights gaps and inconsistencies in care for lupus patients

HSS researchers provide better understanding of the cellular mechanisms driving rheumatoid arthritis

UNC and partners receive NIH funding to identify chlamydia vaccine

Experts find previously unknown bacterial strain of the genus Leptospira

Inhibition of ribosome biogenesis as new treatment strategy for advanced cancers

Researchers create ‘mini-guts’ to explore how gut epithelium respond to gluten in celiac patients

World Asthma Day: How climate change is increasing cases of asthma

Long-standing immunosuppressive drug reduces Zika birth defects in mice

Research in preclinical models suggests promising anti-HIV-1 vaginal microbicide

CU Anschutz researchers identify new immunodeficiency disease

NIH-funded trial demonstrates safety of potential treatment in lung transplant patients

Novel chemical probe enables live imaging of brain immune cells

$30 million federal grant to accelerate chase for universal influenza vaccine

Treatment with antibiotic reduces the size of endometriosis-related lesions in mice

JoVE records a successful MedUni Vienna radiopharmaceutical experiment

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production